Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

MSC engineered to produce BDNF for the treatment of Huntington’s disease

  • Post author:
  • Post published:March 16, 2026
  • Post category:

One in every ten thousand people in the USA has Huntington's disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingMSC engineered to produce BDNF for the treatment of Huntington’s disease

Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells

  • Post author:
  • Post published:March 16, 2026
  • Post category:

Although most individuals are aware that osteoporosis is disease of increased bone fragility that results from estrogen deficiency and aging, most are unaware of the high risk and cost of…

Continue ReadingTreatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells

Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID

  • Post author:
  • Post published:March 16, 2026
  • Post category:

Artemis is a chemical in all cells in the body that is essential for the normal development of the immune system and repairing damaged DNA. Artemis deficiency (AD) causes Severe…

Continue ReadingGene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID

Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury

  • Post author:
  • Post published:March 16, 2026
  • Post category:

The proposed project is designed to assess the safety and preliminary activity of escalating doses of human embryonic stem cell (hESC) derived oligodendrocyte progenitor cells for treatment of spinal cord…

Continue ReadingEvaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury

Harnessing native fat-residing stem cells for bone regeneration

  • Post author:
  • Post published:March 16, 2026
  • Post category:

Like most tissues of the body, bone possesses a natural regenerative system aimed at restoring cells and tissues lost to natural cell aging, disease or injury. These natural regenerative systems…

Continue ReadingHarnessing native fat-residing stem cells for bone regeneration

Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis

  • Post author:
  • Post published:March 16, 2026
  • Post category:

The ability to direct the differentiation of resident mesenchymal stem cells (MSCs) towards the cartilage lineage offers considerable promise for the regeneration of articular cartilage after traumatic joint injury or…

Continue ReadingCartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis

Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy

  • Post author:
  • Post published:March 16, 2026
  • Post category:

Cancer is the leading cause of death for individuals under 85. Relapse and metastatic disease are the leading causes of cancer related mortality. Anti-apoptotic BCL2 family member overexpression has been…

Continue ReadingPreclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy

Induction of immune tolerance after spinal grafting of human ES-derived neural precursors

  • Post author:
  • Post published:March 16, 2026
  • Post category:

Previous clinical studies have shown that grafting of human fetal brain tissue into the CNS of adult recipients can be associated with long-term (more then 10 years) graft survival even…

Continue ReadingInduction of immune tolerance after spinal grafting of human ES-derived neural precursors

GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE

  • Post author:
  • Post published:March 16, 2026
  • Post category:

Continue ReadingGENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE

Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke

  • Post author:
  • Post published:March 16, 2026
  • Post category:

A stroke kills brain cells by interrupting blood flow. The most common “ischemic stroke” is due to blockage in blood flow from a clot or narrowing in an artery. Brain…

Continue ReadingEmbryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 34
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us